• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

47
21
7
6
6

COUNTRY

18
6
4
1
1

CATEGORIES

  • 64
  • 17
  • 13
  • 12
  • 7
  • 7
  • 5
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

17
34
67
126

PUBLISHED

4
8
51
126

PRODUCT TYPE

120
5
1

Search "Biocon: Biosimilars Company Analysis" returned 126 results.

PRODUCT TITLE

Biosimilars in Emerging Economies - Advanced Recombinant Technology Platforms and Low Cost Manufacturing Put India and China at a Strategic Advantage in Biosimilar Production

Biosimilars in Emerging Economies - Advanced Recombinant Technology Platforms and Low Cost Manufacturing Put India and China at a Strategic Advantage in Biosimilar Production Summary GBI Research,...

June 2012
FROM

The Future of Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways

“The Future of Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways” provides insights on the biosimilars market revenues and growth until 2015 Further, the distribution...

December 2009
FROM

Biosimilars in Developed Countries - Launch of Biosimilar mAbs in Europe and New Regulatory Pathways in the US to Spur Market Growth

GBI Research, the leading business intelligence provider, has released its latest report, “Biosimilars in Developed Countries - Launch of Biosimilar mAbs in Europe and New Regulatory Pathways in the...

July 2012
FROM
Tapping Biosimilar Opportunities Tapping Biosimilar Opportunities - Product Thumbnail Image

Tapping Biosimilar Opportunities

Tapping biosimilar opportunities A Follow on biologic (FOB) or Biosimilar, as commonly known, has been one of the most widely discussed topics in the world of pharma in the last few years The approaching...

September 2011
FROM
India Biosimilar Market Analysis India Biosimilar Market Analysis - Product Thumbnail Image

India Biosimilar Market Analysis

As the number of patent expiries of biologic drugs is increasing, Indian companies are developing biosimilar manufacturing capabilities Firms are developing their capabilities by either forming partnerships...

August 2012
FROM
Biosimilars - Global Strategic Business Report Biosimilars - Global Strategic Business Report - Product Thumbnail Image

Biosimilars - Global Strategic Business Report

This report analyzes the worldwide markets for Biosimilars in US$ Million The report provides separate comprehensive analytics for US, Europe, and Japan Annual estimates and forecasts are provided for...

April 2012
FROM
Global Biosimilars Market - Products, Applications and Regulations Global Biosimilars Market - Products, Applications and Regulations - Product Thumbnail Image

Global Biosimilars Market - Products, Applications and Regulations

Off-Patent Biologics to Boost the Growth of Biosimilars Global Market to Reach US$19 4bn by 2018 Several of the leading 25 manufacturers of biosimilars have been entrenched in the market, and have the...

November 2012
FROM
Biocon Limited - Product Pipeline Review - 2012 Biocon Limited - Product Pipeline Review - 2012 - Product Thumbnail Image

Biocon Limited - Product Pipeline Review - 2012

Biocon Limited – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Biocon Limited - Product Pipeline Review - 2012” provides data on the Biocon Limited’s research...

August 2012
FROM

Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment

Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment Summary GBI Research, the leading business intelligence provider,...

April 2011
FROM
Global Biosimilars: A return to optimism? Global Biosimilars: A return to optimism? - Product Thumbnail Image

Global Biosimilars: A return to optimism?

A Critical Strategic Analysis from Espicom Despite some commentators predicting a muted or near nonexistent market for advanced biosimilars, many companies – and some surprising names – are positioning...

January 2012
FROM
Global Biosimilars Industry Global Biosimilars Industry - Product Thumbnail Image

Global Biosimilars Industry

Biosimilar is a term used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator...

October 2012
FROM
Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies - Product Thumbnail Image

Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies

The present Competitive Intelligence Report about Biosimilar and Biosuperior Therapeutic Antibodies 2014 provides a competitor evaluation in the field of recombinant monoclonal and polyclonal antibodies...

March 2014
FROM

Biocon Limited (BIOCON) - Financial and Strategic SWOT Analysis Review

Biocon Limited (BIOCON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData...

June 2014
FROM

PharmaSphere: Global Biosimilars Strategy - Regulatory Landscape, Key Drivers, Markets and Trends in 2013

PharmaSphere: Global Biosimilars Strategy - Regulatory Landscape, Key Drivers, Markets and Trends in 2013 Summary Our "PharmaSphere: Global Biosimilars Strategy - Regulatory Landscape, Key Drivers,...

May 2013
FROM
Strategic Analysis of Indian Biosimilar Market Strategic Analysis of Indian Biosimilar Market - Product Thumbnail Image

Strategic Analysis of Indian Biosimilar Market

This research deliverable provides deep insights into the Biosimilar market in India It also includes an overview of the Indian regulatory and R&D process briefing about the biosimilars, trends in regional/local...

May 2011
FROM
Biocon Limited - Product Pipeline Review - H2 2011 Biocon Limited - Product Pipeline Review - H2 2011 - Product Thumbnail Image

Biocon Limited - Product Pipeline Review - H2 2011

Biocon Limited – Product Pipeline Review – H2 2011 Summary Global Market Direct’s pharmaceuticals report, “Biocon Limited - Product Pipeline Review - H2 2011” provides data on the Biocon Limited’s...

November 2011
FROM
Biosimilars in Emerging Markets Biosimilars in Emerging Markets - Product Thumbnail Image

Biosimilars in Emerging Markets

There are few areas of the pharmaceutical market more hotly debated than biosimilars yet the pathway to developing a viable global product marketplace is not clear Biosimilar interest is being driven...

March 2013
FROM
Global Biosimilars (Follow-on biologics) Market: An Analysis Global Biosimilars (Follow-on biologics) Market: An Analysis - Product Thumbnail Image

Global Biosimilars (Follow-on biologics) Market: An Analysis

Biosimilars or FOBs (Follow-on biologics) refer to generic versions of patented branded biological drugs, developed subsequent to the patent expiry of brand name products The biosimilars market is segmented...

November 2010
FROM

Biosimilars (2009 - 2014)

The impending expiry of several patented blockbuster biopharmaceuticals and the increasing demand from patients, insurers, and government agencies to reduce drug costs have created numerous opportunities...

September 2009
FROM

Biocon Limited - Product Pipeline Review - 2013

Biocon Limited - Product Pipeline Review - 2013 Summary “Biocon Limited - Product Pipeline Review - 2013” provides data on the Biocon Limited’s research and development focus. The report includes...

December 2013
FROM
Loading Indicator